Extract from the Register of European Patents

EP About this file: EP3339321

EP3339321 - MODULATORS OF MYC, METHODS OF USING THE SAME AND METHODS OF IDENTIFYING AGENTS THAT MODULATE MYC [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  04.03.2022
Database last updated on 08.04.2026
FormerThe patent has been granted
Status updated on  26.03.2021
FormerGrant of patent is intended
Status updated on  22.11.2020
FormerExamination is in progress
Status updated on  03.09.2019
FormerRequest for examination was made
Status updated on  04.01.2019
FormerThe application has been published
Status updated on  25.05.2018
Most recent event   Tooltip19.12.2025Lapse of the patent in a contracting state
New state(s): TR
published on 21.01.2026  [2026/04]
Applicant(s)For all designated states
Taiga Biotechnologies, Inc.
12635 East Montview Boulevard
Aurora, CO 80045-7336 / US
[2018/26]
Inventor(s)01 / REFAELI, Yosef
1115 Steele Street
Denver, CO 80206 / US
02 / TURNER, Brian Curtis
655 S. Glencoe Street
Denver, CO 80246 / US
 [2018/33]
Former [2018/26]01 / REFAELI, Yosef
843 Garfield Street
Denver, CO 80206 / US
02 / TURNER, Brian Curtis
655 S. Glencoe Street
Denver, CO 80246 / US
Representative(s)Barker Brettell LLP
100 Hagley Road
Edgbaston
Birmingham B16 8QQ / GB
[2018/26]
Application number, filing date18154875.128.08.2009
[2018/26]
Priority number, dateUS20080092708P28.08.2008         Original published format: US 92708 P
[2018/26]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3339321
Date:27.06.2018
Language:EN
[2018/26]
Type: B1 Patent specification 
No.:EP3339321
Date:28.04.2021
Language:EN
[2021/17]
Search report(s)(Supplementary) European search report - dispatched on:EP24.04.2018
ClassificationIPC:C07K14/82, C07K19/00, A61K38/16
[2018/26]
CPC:
A61P1/16 (EP,IL); C07K14/47 (IL,US); A61K39/39 (IL,US);
A61K38/00 (EP,IL,US); A61P19/02 (EP,IL); A61P29/00 (EP,IL);
A61P31/00 (EP,IL); A61P31/04 (EP,IL); A61P31/06 (EP,IL);
A61P31/12 (EP,IL); A61P31/14 (EP,IL); A61P31/16 (EP,IL);
A61P31/20 (EP,IL); A61P33/00 (EP,IL); A61P37/02 (EP,IL);
A61P37/04 (EP,IL); A61P43/00 (EP,IL); C07K14/001 (IL,US);
C07K14/82 (EP,IL,US); C07K2319/02 (IL,US); C07K2319/21 (IL,US);
Y02A50/30 (EP,IL,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2019/06]
Former [2018/26]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  SM,  TR 
TitleGerman:MODULATOREN VON MYC, VERFAHREN ZUR VERWENDUNG DAVON UND VERFAHREN ZUR IDENTIFIKATION VON MITTELN ZUR MODULIERUNG VON MYC[2018/26]
English:MODULATORS OF MYC, METHODS OF USING THE SAME AND METHODS OF IDENTIFYING AGENTS THAT MODULATE MYC[2018/26]
French:MODULATEURS DE MYC, LEURS PROCÉDÉS D'UTILISATION ET DES PROCÉDÉS D'IDENTIFICATION D'AGENTS MODULANT UN MYC[2018/26]
Examination procedure21.12.2018Amendment by applicant (claims and/or description)
21.12.2018Examination requested  [2019/06]
21.12.2018Date on which the examining division has become responsible
06.09.2019Despatch of a communication from the examining division (Time limit: M04)
14.01.2020Reply to a communication from the examining division
23.11.2020Communication of intention to grant the patent
23.03.2021Fee for grant paid
23.03.2021Fee for publishing/printing paid
23.03.2021Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP09810692.5  / EP2318435
EP15175802.6  / EP2966084
Divisional application(s)EP21170329.3  / EP3916010
Opposition(s)31.01.2022No opposition filed within time limit [2022/14]
Fees paidRenewal fee
02.02.2018Renewal fee patent year 03
02.02.2018Renewal fee patent year 04
02.02.2018Renewal fee patent year 05
02.02.2018Renewal fee patent year 06
02.02.2018Renewal fee patent year 07
02.02.2018Renewal fee patent year 08
02.02.2018Renewal fee patent year 09
28.08.2018Renewal fee patent year 10
26.08.2019Renewal fee patent year 11
20.08.2020Renewal fee patent year 12
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU28.08.2009
AT28.04.2021
CY28.04.2021
CZ28.04.2021
EE28.04.2021
HR28.04.2021
LT28.04.2021
LV28.04.2021
MC28.04.2021
MK28.04.2021
MT28.04.2021
PL28.04.2021
RO28.04.2021
SI28.04.2021
SK28.04.2021
SM28.04.2021
TR28.04.2021
BG28.07.2021
GR29.07.2021
IS28.08.2021
LU28.08.2021
PT30.08.2021
[2026/04]
Former [2024/41]HU28.08.2009
AT28.04.2021
CY28.04.2021
CZ28.04.2021
EE28.04.2021
HR28.04.2021
LT28.04.2021
LV28.04.2021
MC28.04.2021
MK28.04.2021
MT28.04.2021
PL28.04.2021
RO28.04.2021
SI28.04.2021
SK28.04.2021
SM28.04.2021
BG28.07.2021
GR29.07.2021
IS28.08.2021
LU28.08.2021
PT30.08.2021
Former [2024/23]HU28.08.2009
AT28.04.2021
CY28.04.2021
CZ28.04.2021
EE28.04.2021
HR28.04.2021
LT28.04.2021
LV28.04.2021
MC28.04.2021
MK28.04.2021
PL28.04.2021
RO28.04.2021
SI28.04.2021
SK28.04.2021
SM28.04.2021
BG28.07.2021
GR29.07.2021
IS28.08.2021
LU28.08.2021
PT30.08.2021
Former [2023/29]HU28.08.2009
AT28.04.2021
CY28.04.2021
CZ28.04.2021
EE28.04.2021
HR28.04.2021
LT28.04.2021
LV28.04.2021
MC28.04.2021
PL28.04.2021
RO28.04.2021
SI28.04.2021
SK28.04.2021
SM28.04.2021
BG28.07.2021
GR29.07.2021
IS28.08.2021
LU28.08.2021
PT30.08.2021
Former [2023/24]AT28.04.2021
CY28.04.2021
CZ28.04.2021
EE28.04.2021
HR28.04.2021
LT28.04.2021
LV28.04.2021
MC28.04.2021
PL28.04.2021
RO28.04.2021
SI28.04.2021
SK28.04.2021
SM28.04.2021
BG28.07.2021
GR29.07.2021
IS28.08.2021
LU28.08.2021
PT30.08.2021
Former [2022/29]AT28.04.2021
CZ28.04.2021
EE28.04.2021
HR28.04.2021
LT28.04.2021
LV28.04.2021
MC28.04.2021
PL28.04.2021
RO28.04.2021
SI28.04.2021
SK28.04.2021
SM28.04.2021
BG28.07.2021
GR29.07.2021
IS28.08.2021
LU28.08.2021
PT30.08.2021
Former [2022/23]AT28.04.2021
CZ28.04.2021
EE28.04.2021
HR28.04.2021
LT28.04.2021
LV28.04.2021
MC28.04.2021
PL28.04.2021
RO28.04.2021
SK28.04.2021
SM28.04.2021
BG28.07.2021
GR29.07.2021
IS28.08.2021
LU28.08.2021
PT30.08.2021
Former [2022/18]AT28.04.2021
CZ28.04.2021
EE28.04.2021
HR28.04.2021
LT28.04.2021
LV28.04.2021
MC28.04.2021
PL28.04.2021
RO28.04.2021
SK28.04.2021
SM28.04.2021
BG28.07.2021
GR29.07.2021
PT30.08.2021
IS22.12.2021
Former [2022/10]AT28.04.2021
CZ28.04.2021
EE28.04.2021
HR28.04.2021
LT28.04.2021
LV28.04.2021
PL28.04.2021
RO28.04.2021
SK28.04.2021
SM28.04.2021
BG28.07.2021
GR29.07.2021
PT30.08.2021
IS22.12.2021
Former [2022/09]AT28.04.2021
CZ28.04.2021
HR28.04.2021
LT28.04.2021
LV28.04.2021
PL28.04.2021
RO28.04.2021
SK28.04.2021
SM28.04.2021
BG28.07.2021
GR29.07.2021
IS28.08.2021
PT30.08.2021
Former [2022/07]AT28.04.2021
HR28.04.2021
LT28.04.2021
LV28.04.2021
PL28.04.2021
SM28.04.2021
BG28.07.2021
GR29.07.2021
IS28.08.2021
PT30.08.2021
Former [2021/52]AT28.04.2021
HR28.04.2021
LT28.04.2021
LV28.04.2021
PL28.04.2021
BG28.07.2021
GR29.07.2021
IS28.08.2021
PT30.08.2021
Former [2021/51]AT28.04.2021
HR28.04.2021
LT28.04.2021
LV28.04.2021
BG28.07.2021
GR29.07.2021
IS28.08.2021
PT30.08.2021
Former [2021/50]AT28.04.2021
HR28.04.2021
LT28.04.2021
LV28.04.2021
BG28.07.2021
GR29.07.2021
PT30.08.2021
Former [2021/49]AT28.04.2021
HR28.04.2021
LT28.04.2021
LV28.04.2021
BG28.07.2021
GR29.07.2021
Former [2021/47]AT28.04.2021
LT28.04.2021
BG28.07.2021
Former [2021/46]AT28.04.2021
LT28.04.2021
Documents cited:Search[XY] US2001049393  (COLLER HILARY A et al.)
 [XY] WO2007047583  (NAT JEWISH MED & RES CENTER et al.)
 [E] WO2009139930  (TAIGA BIOTECHNOLOGIES INC et al.)
 [X]   COLLER HILARY A ET AL: "Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion", PROCEEDINGS NATIONAL ACADEMY OF SCIENCES PNAS, NATIONAL ACADEMY OF SCIENCES, US, vol. 97, no. 7, 28 March 2000 (2000-03-28), pages 3260 - 3265, XP002185706, ISSN: 0027-8424, DOI: 10.1073/PNAS.97.7.3260

DOI:   http://dx.doi.org/10.1073/pnas.97.7.3260
 [Y]   REFAELI Y ET AL: "The protooncogene MYC can break B cell tolerance", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, WASHINGTON, DC; US, vol. 102, no. 11, 1 March 2005 (2005-03-01), pages 4097 - 4102, XP008116683, ISSN: 0027-8424, DOI: 10.1073/PNAS.0409832102

DOI:   http://dx.doi.org/10.1073/pnas.0409832102
by applicantUS4816567
 US2008070256
   MORRISON ET AL., PROC. NATL ACAD. SCI., vol. 81, 1984, pages 6851 - 6855
   JONES ET AL., NATURE, vol. 321, 1986, pages 522 - 525
   REICHMANN ET AL., NATURE, vol. 332, 1988, pages 323 - 329
   PRESTA, CURR. OP. STRUCT. BIOL., vol. 2, 1992, pages 593 - 596
   "NCBI", Database accession no. NP002458.2
   BATZER ET AL., NUCLEIC ACID RES., vol. 19, 1991, pages 5081
   OHTSUKA ET AL., J. BIOL. CHEM., vol. 260, 1985, pages 2605 - 2608
   ROSSOLINI ET AL., MOL. CELL. PROBES, vol. 8, 1994, pages 91 - 98
   "NCBI", Database accession no. NM_002467
   KARLIN; ALTSCHUL, PROC. NATL. ACAD. SCI. USA, vol. 87, 1990, pages 2264 - 2268
   KARLIN; ALTSCHUL, PROC. NATL. ACAD. SCI. 5 USA, vol. 90, 1993, pages 5873 - 5877
   ALTSCHUL ET AL., J. MOL. BIOL., vol. 215, 1990, pages 403 - 410
   ALTSCHUL ET AL., NUCLEIC ACIDS RES., vol. 25, 1997, pages 3389 - 3402
   HENIKOFF ET AL., PROC. NATL ACAD. SCI. USA, vol. 89, 1992, pages 10915 - 10919
   KOHLER ET AL., NATURE, vol. 256, 1975, pages 495
   GODING: "Monoclonal Antibodies: Principles and Practice", 1986, ACADEMIC PRESS
   WARD ET AL., NATURE, vol. 341, 1989, pages 544 - 546
   HUSE ET AL., SCIENCE, vol. 246, 1989, pages 1275 - 1281
   MCCAFFERTY, NATURE, vol. 348, 1990, pages 552 - 554
   CLACKSON ET AL., NATURE, vol. 352, 1991, pages 624 - 628
   MARKS ET AL., J. MOL. BIOL., vol. 222, 1991, pages 581 - 597
   SAMBROOK ET AL.: "Molecular Cloning: A Laboratory Manual", 1989
   SAMBROOK; RUSSEL: "Molecular Cloning: A Laboratory Manual", 2001
   "Current Protocols in Molecular Biology", 1987
   "Current Protocols in Nucleic Acid Chemistry", 2000, JOHN WILEY & SONS, INC.
   "Remington: The Science and Practice of Pharmacy", 1995, MACK PUBLISHING COMPANY
   HOOVER, JOHN E.: "Remington's Pharmaceutical Sciences", 1975, MACK PUBLISHING CO.
   "Pharmaceutical Dosage Forms", 1980, MARCEL DECKER
   "Pharmaceutical Dosage Forms and Drug Delivery Systems", 1999, LIPPINCOTT WILLIAMS & WILKINS
   "Remington's Pharmaceutical Sciences", 2000
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.